Evolution of the Average Target: RH

Data source: RH(RH)

Evolution of the Target Price: RH

Data source: RH(RH)

Changes in Analyst Recommendations: RH

Data source: RH(RH)
f5837e35efdb779d5d34c.FIatOUWoSOWLuHgdAM9r7qyOPyDouETErk2ahN1oZlM.YezEahT5BLDbjxBNQvlT2pnDDU-w9giD9Arw0L8NMQIg45h6fIV9qvmBMQ~3b681418b9e3bc771f51440de3009a1f
11/09 UBS Adjusts Price Target on RH to $154 From $155, Keeps Neutral Rating MT
11/09 BofA Securities Adjusts RH Price Target to $114 From $156, Maintains Underperform Rating MT
08/07 Goldman Sachs Upgrades RH to Neutral From Sell, Lifts Price Target to $155 From $86 MT
10/06 RH Q1 Unlikely to Show Business Inflection, UBS Says MT
09/06 UBS Adjusts Price Target on RH to $155 From $160, Maintains Neutral Rating MT
02/04 Guggenheim Lowers Price Target on RH to $200 From $275, Keeps Buy Rating MT
02/04 RH Facing Near-Term Challenges From Execution, Supply Chain Issues, Morgan Stanley Says MT
01/04 Morgan Stanley Lowers Price Target on RH to $240 From $275, Keeps Overweight Rating MT
20/12 JPMorgan Cuts Price Target on RH to $225 From $275, Maintains Overweight Rating MT
13/12 Stifel Downgrades RH to Hold From Buy, Adjusts Price Target to $165 From $320 MT
02/10/25 William Blair Downgrades RH to Market Perform From Outperform MT
12/09/25 Telsey Advisory Downgrades RH to Market Perform From Outperform, Adjusts Pt to $220 From $255 MT
25/06/25 RH Shares Fall After Goldman Sachs Downgrade MT
24/06/25 Goldman Sachs Downgrades RH to Sell From Neutral, Adjusts Price Target to $179 From $199 MT
06/06/25 UBS Adjusts RH Price Target to $215 From $235, Maintains Neutral Rating MT
15/05/25 BofA Securities Adjusts Price Target on RH to $172 From $144 MT
08/04/25 RH Cash Flow, Demand Guidance Eases Tariff Concerns, Wedbush Says MT
03/04/25 RH Earnings Troubles Exacerbated by Trump Tariffs, Wedbush Says; Shares Down Pre-Bell MT
03/04/25 Wedbush Adjusts RH Price Target to $250 From $350, Maintains Outperform Rating MT
03/04/25 UBS Adjusts Price Target on RH to $235 From $250, Keeps Neutral Rating MT
27/03/25 RH Could See Solid Sales, Soft Margins for Fiscal Q4, Wedbush Says MT
27/03/25 BofA Securities Cuts RH Price Target to $410 From $510, Maintains Buy Rating MT
26/03/25 Wedbush Cuts Price Target on RH to $350 From $500, Keeps Outperform Rating MT
21/03/25 UBS Adjusts Price Target on RH to $250 From $440, Keeps Neutral Rating MT
30/01/25 Goldman Sachs Upgrades RH to Neutral From Sell, Raises Price Target to $374 From $261 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+10.55%
+1.02%
+31.51%
+31.07%
+12.84%
+33.61%
+34.79%
+27.99%
+5.56%
Average +20.99%
Weighted average by Cap. +11.79%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
126.54USD
Average target price
166.41USD
Spread / Average Target
+31.51%
High Price Target
258.00USD
Spread / Highest target
+103.89%
Low Price Target
81.00USD
Spread / Lowest Target
-35.99%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
-
ESG MSCI
BB
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!